From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves expanded age range for anti-seizure medication

from HCPLive

The U.S. Food and Drug Administration has approved a supplemental New Drug Application from Eisai Inc. for the use of Banzel as an adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in children aged 1 to 4 years. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063